TBC-1002 Trademark

Trademark Overview

On Friday, May 19, 2017, a trademark application was filed for TBC-1002 with the United States Patent and Trademark Office. The USPTO has given the TBC-1002 trademark a serial number of 87456851. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 4, 2021. This trademark is owned by Tesorx Pharma, LLC. The TBC-1002 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of bladder cancer
tbc-1002

General Information

Serial Number87456851
Word MarkTBC-1002
Filing DateFriday, May 19, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of bladder cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTesorx Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameTesorx Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Thursday, April 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2020EXTENSION 5 GRANTED
Monday, March 30, 2020EXTENSION 5 FILED
Wednesday, April 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 30, 2020TEAS EXTENSION RECEIVED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019EXTENSION 4 GRANTED
Thursday, October 3, 2019EXTENSION 4 FILED
Thursday, October 3, 2019TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019EXTENSION 3 GRANTED
Monday, May 20, 2019EXTENSION 3 FILED
Monday, May 20, 2019TEAS EXTENSION RECEIVED
Wednesday, November 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 12, 2018EXTENSION 2 GRANTED
Monday, November 12, 2018EXTENSION 2 FILED
Monday, November 12, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2018EXTENSION 1 GRANTED
Friday, April 6, 2018EXTENSION 1 FILED
Friday, April 6, 2018TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, August 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 18, 2017ASSIGNED TO EXAMINER
Thursday, May 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 23, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cancer preparations treatment bladder pharmaceutical drugs namely anti pharmaceuticals